| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-14 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-14 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-11 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-10 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |